ICN/Elder
Executive Summary
ICN/Elder: SPI Pharmaceuticals unit purchases Elder Pharmaceuticals for undisclosed cash. Elder manufactures Psoralen and has annual sales in the $5 mil. range. Elder gives SPI "an entry into the Rx dermatological drug market," SPI President Dominic Liuzzi said.